Stocks Screener

Search any stock or ticker

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

How This Company Makes Money

Dividend Analysis CLPBY

Max Ratio

1.69

Dividend Yield

0.62 %

5Y Dividend Growth

83.00 %

Consecutive Years

5 years

5Y Average Payout Ratio

12.28 %

Dividend History CLPBY

1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021
Forward Annual Dividend Yield 0.62 %
Consecutive Years 5
Forward Annual Dividend 0.48 EUR
Consistent Years 5
Dividend CAGR 3Y 5.02 %
Continuous Dividends
Dividend CAGR 5Y 12.89 %
Payout Ratio TTM 8.15 %
Dividend CAGR 10Y
Ex Dividend Date 05/08/2025

The 5 Pillars Formula Checklist

The Five-Pillar Secret Formula Checklist is our simple, proven way to separate strong, lasting businesses from the rest. We look at five key pillars—sales growth, profit growth, Net Income, dividend safety, and debt levels. Together with Financial Score, they tell us if a company can keep growing, stay financially solid, and reliably pay dividends for decades.

Sales Growth CLPBY

Sales Growth – The Foundation of a Strong Business. Consistent revenue growth over the past 10-15 years is a key sign of a thriving company. It shows that demand for its products and services is increasing, allowing it to expand operations, gain market share, and invest in future growth.
1 year
3 years
5 years
10 years

Profit Growth / Profit Margin CLPBY

The Fuel for Company Growth. Revenue alone isn’t enough—what truly matters is how efficiently a company turns that revenue into consistent, growing profits. Profitability is the foundation of sustainable growth and long-term financial strength.
1 year
3 years
5 years
10 years

Net Income CLPBY

The True Measure of Financial Strength. Net income is what remains after all expenses, taxes, and costs. This is the company’s real earning power.
1 year
3 years
5 years
10 years

Payout Ratio TTM CLPBY

Dividend Payout Safety – Protecting Your Passive Income. A high dividend yield is meaningless if the company can’t afford to sustain it. We evaluate payout ratios to ensure the company is not overextending itself. The best companies have a balanced approach—paying generous dividends while still reinvesting in future growth. Dividend safety is crucial for long-term income stability.
1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021

Debt Ratio CLPBY

Debt Burden – Avoiding Financial Traps. Too much debt can cripple a company, even if its revenues and profits look great. We analyze how well a company manages its liabilities, ensuring that debt levels are under control.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021

Full Financial Performance

See how the company makes money over time—revenue, profits, dividends, and more. The charts on the right give you a quick view of growth trends so you can instantly spot consistency or red flags.

Coloplast A/S CLPBY

1 year
3 years
5 years
10 years
Results 2019 Dynamics
* The data for this period has not yet been published

Bottom Line

Valuation Check

Shows if a stock is priced fairly by looking at peers and the company’s own history — a quick way to see if it’s a bargain or overpriced.

Value vs Peers

The company is measured against at least 10 rivals in the same sector. If it earns 25% more profit per share than the average, it’s Undervalued. If it earns 25% less, it’s Overvalued. In short: stronger earnings per share mean you’re getting a bargain, weaker ones mean you’re overpaying.

Value vs Itself CLPBY

P/E shows how many dollars investors pay in the stock price for each $1 of profit the company earns per share. Today’s P/E is compared with the company’s 10-year average. If the ratio is above that norm, you’re paying up for each dollar of profit. If it’s below, you’re getting more earnings for less.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021
Trailing PE 35.98
Forward PE 22.17
Enterprise Value Revenue 5.46
Price Sales TTM 0.63
Enterprise Value EBITDA 18.19
Price Book MRQ 8.11

Coloplast A/S Dividends: 0.50 % Yield, History, Payment Schedule

CLPBY
Current price
8.97 USD -0.08 USD (-0.88%)
Last closed 77.72 EUR
ISIN DK0060448595
Sector Healthcare
Industry Medical Instruments & Supplies
Exchange XETRA
Capitalization 17 648 025 338 EUR
Yield for 12 month -32.78 %
1Y
3Y
5Y
10Y
15Y
CLPBY
11/21/2021 - 11/28/2021

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Advanced Highlights

Current Year

+27 089 635 023 EUR

Last Year

+24 554 053 203 EUR

Current Quarter

+6 973 351 110 EUR

Last Quarter

+6 945 289 334 EUR

Current Year

+18 309 306 039 EUR

Last Year

+16 364 023 702 EUR

Current Quarter

+4 715 380 421 EUR

Last Quarter

+4 738 431 165 EUR
EBITDA 8 649 039 580 EUR
Operating Margin TTM 28.32 %
Price to Earnings 35.98
Return On Assets TTM 10.01 %
PEG Ratio 2.31
Return On Equity TTM 21.35 %
Wall Street Target Price
Revenue TTM 27 935 497 998 EUR
Book Value 71.69 EUR
Revenue Per Share TTM
Dividend Share 23.05 EUR
Quarterly Revenue Growth YOY 0.10 %
Dividend Yield 0.62 %
Gross Profit TTM 18 986 796 889 EUR
Earnings per share 2.16 EUR
Diluted Eps TTM 2.16 EUR
Most Recent Quarter II 2025
Quarterly Earnings Growth YOY -33.50 %
Profit Margin 13.04 %

Technical Indicators CLPBY

For 52 Weeks

72.96 EUR 114.50 EUR
50 Day MA 78.37 EUR
Shares Short Prior Month
200 Day MA 85.33 EUR
Short Ratio
Shares Short
Short Percent